2.725EUR-3.20%Mkt Cap: 206.88M EURP/E: —Last update: 2026-06-01
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. Th…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap206.88M EUR
Enterprise Value458.06M EUR
Revenue (TTM)144.31M EUR
Gross Profit61.35M EUR
Net Income (TTM)-100.30M EUR
Revenue/Share1.901 EUR
Last Price2.725 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees553
CountryES
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)18.30
PEG—
EV/EBITDA72.85
EV/Revenue3.17
P/S1.48
P/B1.41
EPS (TTM)-0.73
EPS (Forward)0.15
52W Range
2.48022% of range3.590
52W High3.590 EUR
52W Low2.480 EUR
Profitability
Gross Margin43.51%
Oper. Margin-41.77%
EBITDA Margin4.36%
Profit Margin-71.13%
ROE-66.05%
ROA-20.30%
Growth
Revenue Growth5.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.56M EUR
CapEx (TTM)12.52M EUR
FCF Margin-89.74%
FCF Yield-62.60%
Net Debt244.28M EUR
Net Debt/EBITDA38.85
Balance Sheet
Debt/Equity1.70
Current Ratio0.81
Quick Ratio0.16
Book Value/Sh2.001 EUR
Cash/Share0.1790 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)4.833 EUR
Target Range4.000 EUR – 5.500 EUR
# Analysts3
Ownership
Shares Out.75.92M
Float38.41M
Insiders54.56%
Institutions5.60%
Technical
SMA 502.818 (-3.3%)
SMA 2002.899 (-6.0%)
Beta0.55
S&P 52W Chg27.94%
Avg Vol (30d)54.99K
Avg Vol (10d)58.25K
Technical Indicators
RSI (14)53.3
MACD-0.0144
MACD Signal-0.0281
MACD Hist.+0.0138
BB Upper2.861 EUR
BB Middle2.755 EUR
BB Lower2.648 EUR
BB Width7.75%
ATR (14)0.0876 EUR
Vol Ratio (20d)0.56x